Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald Bunjes

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Plos One|January 21, 2017
Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors-A Retrospective StudyChristine Neuchel, Daniel Fürst, Dietger Niederwieser, et al.
Cancer|February 23, 2018
T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT)Simona Sestili, Myriam Labopin, Annalisa Ruggeri, et al.
Haematologica|January 19, 2010
High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myelomaJochen Greiner, Anita Schmitt, Krzysztof Giannopoulos, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 13, 2020
Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomesMobil Akhmedov, Verena Wais, Elisa Sala, et al.
Blood|May 27, 2006
Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemiaThorsten Zenz, Matthias Ritgen, Peter Dreger, et al.
Haematologica|September 9, 2017
Human leukocyte antigen-E mismatch is associated with better hematopoietic stem cell transplantation outcome in acute leukemia patientsChrysanthi Tsamadou, Daniel Fürst, Vladan Vucinic, et al.
British Journal of Haematology|August 4, 2004
CD34 cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patientsMark Ringhoffer, Markus Wiesneth, Stephanie Harsdorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemiaOlle Ringdén, Myriam Labopin, Gerhard Ehninger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2006
Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemiaGerhard Glatting, Marguerite Müller, Bernd Koop, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 18, 2008
First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidineAndreas K Buck, Martin Bommer, Malik E Juweid, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Plos One|January 21, 2017
Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors-A Retrospective StudyChristine Neuchel, Daniel Fürst, Dietger Niederwieser, et al.
Cancer|February 23, 2018
T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT)Simona Sestili, Myriam Labopin, Annalisa Ruggeri, et al.
Haematologica|January 19, 2010
High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myelomaJochen Greiner, Anita Schmitt, Krzysztof Giannopoulos, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 13, 2020
Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomesMobil Akhmedov, Verena Wais, Elisa Sala, et al.
Blood|May 27, 2006
Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemiaThorsten Zenz, Matthias Ritgen, Peter Dreger, et al.
Haematologica|September 9, 2017
Human leukocyte antigen-E mismatch is associated with better hematopoietic stem cell transplantation outcome in acute leukemia patientsChrysanthi Tsamadou, Daniel Fürst, Vladan Vucinic, et al.
British Journal of Haematology|August 4, 2004
CD34 cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patientsMark Ringhoffer, Markus Wiesneth, Stephanie Harsdorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemiaOlle Ringdén, Myriam Labopin, Gerhard Ehninger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2006
Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemiaGerhard Glatting, Marguerite Müller, Bernd Koop, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 18, 2008
First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidineAndreas K Buck, Martin Bommer, Malik E Juweid, et al.
Pageof 11